PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2008
CASE
AUTH/2083/1/08 Roche Products

Roche breached Clause 9.9 after GP received unsolicited promotional email about Tamiflu via an agency (AUTH/2083/1/08)

A GP complained about an unsolicited promotional Tamiflu email sent to an NHS address via an agency. The Panel found no evidence…

2015
CASE
AUTH/2813/12/15 Pfizer

AUTH/2813/12/15: Anonymous (non-contactable) v Pfizer β€” exhibition stand hospitality at ESC Congress (No breach)

Anonymous HCP alleged Pfizer’s ESC 2015 congress stands were extravagant and created a party atmosphere, including flavoured iced drinks. Panel found hospitality…

2016
CASE
AUTH/2852/6/16 Grünenthal ⭐ Case of the Week

AUTH/2852/6/16: Ex-employee complaint about MSL proactive targeting at GrΓΌnenthal (No breach)

An ex-employee alleged GrΓΌnenthal’s MSLs were pushed into proactive targeting of oncology/palliative HCPs as disguised promotion of Palexia Oral Solution. The PMCPA…

2016
CASE
AUTH/2917/12/16 Janssen

AUTH/2917/12/16: Janssen representative failed to disclose family links in territory (breach Clause 15.2; no breach Clauses 2 and 9.1)

Anonymous GP alleged a Janssen rep was hired due to family influence in local diabetes roles. Panel found the rep failed to…

2016
CASE
AUTH/2864/8/16 Boehringer Ingelheim

AUTH/2864/8/16: Anonymous (non-contactable) v Boehringer Ingelheim – consultant/training company engagement (No breach)

Anonymous complaint alleged industry-funded audits/training via a nurse-owned consultancy influenced prescribing in a CCG. Panel found no evidence to support inducement allegations;…

2016
CASE
AUTH/2918/12/16 GlaxoSmithKline

AUTH/2918/12/16: Ex-employee v GlaxoSmithKline (Relvar Ellipta cost calculator) – No breach

An ex-employee found a Relvar Ellipta cost calculator via search engines that appeared to lack PI, AE statement and black triangle. Panel…

2012
CASE
Novo Nordisk

Sanofi v Novo Nordisk: Tresiba leavepiece claims (75% less variability; 142 fewer nocturnal hypoglycaemic events) ruled misleading

Novo Nordisk’s Tresiba leavepiece overstated clamp-study variability data and visually exaggerated a nocturnal hypoglycaemia comparison. PMCPA ruled breaches of Clauses 7.2, 7.3,…

2017
CASE
AUTH/2949/3/17 A Menarini ⭐ Case of the Week

A. Menarini: Broken website links and missing Yellow Card reference on products page (AUTH/2949/3/17)

A hospital doctor couldn’t find working adverse event reporting or a Yellow Card link on Menarini’s website. Panel ruled breaches for missing…

2018
CASE
AUTH/3022/2/18 Servier Laboratories

AUTH/3022/2/18 & AUTH/3023/2/18: Health professionals v Servier (alleged Windsor Castle meeting sponsorship) – No breach

Two HCPs alleged Servier sponsored a learned society weekend meeting at Windsor Castle. Servier showed it declined sponsorship due to venue risk…

2017
CASE
AUTH/2997/12/17 AbbVie

AbbVie breached certification rules for an uncoded β€˜Pathways’ workshop document at a Synagis promotional meeting (AUTH/2997/12/17)

A health professional alleged improper case-study promotion of Synagis. Panel found no misleading promotion, but ruled the β€˜Pathways’ scenarios document was promotional…

2007
CASE
AUTH/1977/3/07 AstraZeneca

AUTH/1977/3/07: Pfizer v AstraZeneca – statin β€˜NICE guidance’ insert and PCT guideline leaflet (Crestor)

AstraZeneca-supported statin materials were ruled disguised promotion for Crestor, with misleading cost/safety content and missing prescribing information. Serious process failures led to…

2007
CASE
AUTH/2054/10/07 Sanofi

AUTH/2054/10/07: Anonymous representative v Sanofi-Aventis – call frequency targets and bonus scheme (No breach)

Anonymous caller alleged Sanofi-Aventis incentivised reps to see key customers 9–12 times, breaching call frequency rules. Panel found targets were team-based and…

2007
CASE
AUTH/2005/5/07 Pfizer ⭐ Case of the Week

AUTH/2005/5/07: GP v Pfizer – Celebrex journal ad claim β€˜relieve my pain’ (No breach)

A GP alleged a Celebrex journal ad implied guaranteed 100% pain relief. The Panel found the wording was an aspiration and not…

GrΓΌnenthal

GrΓΌnenthal Versatis BMJ ad: headline claim implied broader neuropathic pain use (breach upheld for Clause 3.2; other breaches overturned on appeal)

BMJ ad for Versatis said β€œNew for burning, shooting, stabbing pains”. Panel found this implied use beyond PHN (breach 3.2). On appeal,…

2007
CASE
AUTH/1956/2/07 Pfizer

GP v Pfizer: Exubera journal ad found misleading due to inhaler image scale (AUTH/1956/2/07)

A GP said a BMJ ad for Exubera misled on how large the inhaler was. The Panel agreed the artwork implied the…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training